CINECA IRIS Institutional Research Information System

PIRRO, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.796
EU - Europa 1.729
AS - Asia 597
SA - Sud America 29
OC - Oceania 16
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.784
IT - Italia 408
CN - Cina 282
DK - Danimarca 239
SE - Svezia 178
IE - Irlanda 171
FR - Francia 145
DE - Germania 131
UA - Ucraina 97
FI - Finlandia 84
SG - Singapore 60
AT - Austria 59
IN - India 57
JP - Giappone 57
KR - Corea 57
GB - Regno Unito 56
PL - Polonia 38
ES - Italia 33
VN - Vietnam 23
BE - Belgio 20
BR - Brasile 17
CZ - Repubblica Ceca 16
AU - Australia 15
TR - Turchia 13
CH - Svizzera 8
GR - Grecia 8
CA - Canada 7
NL - Olanda 7
EG - Egitto 6
HK - Hong Kong 6
JO - Giordania 6
RO - Romania 6
IR - Iran 5
PK - Pakistan 5
PT - Portogallo 5
RS - Serbia 5
RU - Federazione Russa 5
SN - Senegal 5
TW - Taiwan 5
CL - Cile 4
ID - Indonesia 4
MX - Messico 4
BG - Bulgaria 3
DZ - Algeria 3
EC - Ecuador 3
IQ - Iraq 3
MK - Macedonia 3
MY - Malesia 3
TH - Thailandia 3
UZ - Uzbekistan 3
AR - Argentina 2
AF - Afghanistan, Repubblica islamica di 1
BT - Bhutan 1
CO - Colombia 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
LV - Lettonia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.183
Salva come PNG Salva come JPEG
Città #
Ann Arbor 529
Chandler 437
Beijing 167
Dublin 161
Houston 136
Fairfield 131
Torino 104
Villeurbanne 94
Ashburn 92
Nyköping 80
Dearborn 78
Wilmington 74
Jacksonville 70
Woodbridge 67
Princeton 61
Vienna 58
Medford 54
Redwood City 50
Cambridge 49
Seattle 49
Fremont 32
Singapore 32
Turin 29
Pisa 28
New York 27
Warsaw 27
Boston 24
Milan 24
Boardman 17
Dong Ket 16
Munich 15
Brussels 14
Brno 13
Hefei 13
Nanjing 13
Florence 12
Los Angeles 12
San Diego 12
Shanghai 12
Tokyo 11
Guangzhou 10
London 10
West Jordan 10
Cork 8
Paris 8
Düsseldorf 7
Mumbai 7
Shenzhen 7
Valencia 7
Würzburg 7
Cuneo 6
Hyderabad 6
Jinan 6
Kunming 6
Nanchang 6
Piemonte 6
São Paulo 6
Bangalore 5
Belgrade 5
Catania 5
Fürstenzell 5
Helsinki 5
Madrid 5
Norwalk 5
Phoenix 5
Rome 5
Taipei 5
Verona 5
Washington 5
Zurich 5
Columbus 4
Esslingen am Neckar 4
Falls Church 4
Hong Kong 4
Istanbul 4
Komancza 4
Kumar 4
Nottingham 4
Philadelphia 4
Pune 4
Siena 4
Tianjin 4
Toronto 4
Amman 3
Anghiari 3
Baghdad 3
Bari 3
Bobrowniki Male 3
Boulder 3
Cardenal 3
Copenhagen 3
Dallas 3
Elche 3
Fuzhou 3
Grafing 3
Hamamatsu 3
Heidelberg 3
Islamabad 3
Kharkiv 3
Konya 3
Totale 3.215
Salva come PNG Salva come JPEG
Nome #
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 408
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 407
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 384
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 191
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 181
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 160
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib 151
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 151
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia 150
Procedimento cromatografico di dosaggio di DDT, DDD, DDA, e DDE 146
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 145
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 135
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 133
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 132
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration 131
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 129
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant. 122
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 117
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions 108
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 98
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 93
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 93
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 92
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 90
New hplc–uv validated method for therapeutic drug monitoring of antifungal agents in acute myeloid leukemia 77
Clinical relevance of deferasirox trough levels in β-thalassemia patients 74
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 73
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 72
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 71
Salicylic acid inhibits dimethylbenzanthracene (DMBA) induced mammary carcinogenesis in a dose dipendent manner 69
Antineoplastic effects of SU5416, a novel vascular endothelial growth factor pathway inhibitor, in an oral cancer model 68
Quantification of imatinib plasma levels in patients with chronic myeloid leukemia: Comparison between HPLC-UV and LC-MS/MS 68
Evaluating the impact of angiogenetic inhibitors on chemical carcinogenesis of oral tumors in the buccal pouch Syrian hamster model 67
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma 67
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 67
EVALUTATION OF THE CONTROL OF PAIN IN PATIENTS WITH BONE METASTASIS UNDERGOING MEDICAL TREATMENT WITH BISPHOSPHONATES 64
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico 62
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 62
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 61
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 61
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. 53
Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administration 51
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 48
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 46
Salicylate counteracts streptozotocin induced diabetes mellitus in rat 44
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients 40
New HPLC MS method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib and nilotinib. 40
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib in chronic myeloid leukaemia patients 34
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 21
Evaluation of the control of pain in patients with bone metastasis undergoing medical treatment with bisphosphonates 8
VALIDATED MICROBIOLOGICAL ASSAY FOR JOSAMYCIN DETERMINATION IN ITS PHARMACEUTICAL FORMULATIONS 7
Therapeutic drug monitoring: hydroquinidine administration in a newborn infant with short QT syndrome. A case report 6
Evaluation of nausea and vomiting in oncology patients treated with chemotherapy: a retrospective study 5
The importance of monitoring circulating mitotane levels in the management of adrenocortical cancer patients 5
Totale 5.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.166
article - articoli 0
book - libri 0
conference - conferenze 5.198
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020891 0 27 35 79 78 174 99 49 69 103 78 100
2020/2021613 85 41 35 39 53 49 32 23 73 35 70 78
2021/20221.013 69 65 68 84 53 90 94 65 42 46 192 145
2022/20231.113 114 123 65 124 84 252 53 76 107 29 64 22
2023/2024393 46 59 26 16 27 47 8 22 13 36 34 59
2024/202528 28 0 0 0 0 0 0 0 0 0 0 0
Totale 5.438